Torrent Pharmaceuticals Limited
TORNTPHARM
Ранг среди акций
#1202
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
Цена акции
$50.34
Рыночная капитализация
$19.15B
Изменение (1 день)
-0.07%
Изменение (1 год)
23.64%
Страна
IN
Торговля Torrent Pharmaceuticals Limited (TORNTPHARM)
Категория
Healthcare
Операционная маржа для Torrent Pharmaceuticals Limited (TORNTPHARM)
Операционная маржа на October 2026 TTM: 23.45%
Согласно последним финансовым отчетам и цене акций Torrent Pharmaceuticals Limited, текущая операционная маржа (TTM) составляет 23.45%. В конце 2024 она составила 51.25%.
История операционной маржи Torrent Pharmaceuticals Limited с 2005 по 2026
Операционная маржа на конец каждого года
| Год | Операционная маржа | Изменить |
|---|---|---|
| 2026 (TTM) | 23.45% | -54.14% |
| 2025 | 51.13% | -0.23% |
| 2024 | 51.25% | 5.71% |
| 2023 | 48.48% | 3.08% |
| 2022 | 47.03% | -3.77% |
| 2021 | 48.87% | 1.14% |
| 2020 | 48.32% | 5.59% |
| 2019 | 45.76% | 1.55% |
| 2018 | 45.06% | -0.73% |
| 2017 | 45.39% | -24.75% |
| 2016 | 60.32% | 30.65% |
| 2015 | 46.17% | 0.00% |
| 2014 | 46.17% | 127.21% |
| 2013 | 20.32% | 17.73% |
| 2012 | 17.26% | 3.23% |
| 2011 | 16.72% | -11.91% |
| 2010 | 18.98% | 40.70% |
| 2009 | 13.49% | 8.35% |
| 2008 | 12.45% | 29.15% |
| 2007 | 9.64% | 12.22% |
| 2006 | 8.59% | -15.62% |
| 2005 | 10.18% | 0.00% |
Операционная маржа для аналогичных компаний или конкурентов
| Компания | Операционная маржа | Разница в операционной марже | Страна |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -99.02% |
IN
|
Что такое операционная маржа компании?
Операционная маржа — это ключевой показатель прибыльности компании. Более высокая операционная маржа обычно означает, что компания может продавать свои товары или услуги значительно дороже их себестоимости. Она рассчитывается путем деления прибыли компании на её выручку.